Evidence supporting the use of: L-carnitine
For the health condition: Nerve Damage

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

L-carnitine, particularly in its acetylated form (acetyl-L-carnitine or ALCAR), has been studied for its potential role in supporting and treating nerve damage, especially in the context of peripheral neuropathy. Several randomized controlled trials and meta-analyses have explored the efficacy of acetyl-L-carnitine in reducing symptoms associated with nerve damage, such as pain, numbness, and tingling, particularly in diabetic neuropathy and chemotherapy-induced peripheral neuropathy.

The mechanism behind L-carnitine’s neuroprotective effects is thought to involve enhancement of mitochondrial energy production, reduction of oxidative stress, and promotion of nerve regeneration. Acetyl-L-carnitine may also increase the synthesis of acetylcholine, a neurotransmitter important for nerve function, and upregulate nerve growth factors.

Clinical evidence is moderate: some studies report statistically significant improvements in neuropathic symptoms and nerve conduction velocities, while others show more limited or mixed results. A 2008 meta-analysis in Diabetes Care concluded that acetyl-L-carnitine may improve pain and promote nerve fiber regeneration in diabetic neuropathy, with relatively few side effects. However, more recent reviews note that while the evidence is encouraging, larger and longer-term studies are still needed to confirm its efficacy and establish optimal dosing.

In summary, L-carnitine—especially as ALCAR—has a scientific basis for use in supporting nerve health and treating certain types of nerve damage, although the current level of evidence is moderate rather than definitive.

More about l-carnitine
More about Nerve Damage